NYSE:ZBHMedical Equipment
Zimmer Biomet Holdings (ZBH) Raised Guidance On A Q2 Beat, Does It Look Fairly Valued?
Zimmer Biomet Holdings (ZBH) just reported a second-quarter update that caught investor attention. Revenue and earnings topped analyst expectations, full-year guidance was raised, and the Paragon 28 acquisition and US commercial changes featured prominently.
See our latest analysis for Zimmer Biomet Holdings.
Zimmer Biomet Holdings' recent Q2 beat and higher guidance have come alongside a clear shift in market sentiment, with the share price at $97.19 and a 90 day share price return of...